DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Discussions regarding Medicare Part D
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
Copyright/Patent/Trademark CPT
Discussions regarding intellectual property protection and innovation.
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH LEE WRIGHT | — |
Health Issues HCR
Discussions related to drug importation and IPAB; Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #); Discussions regarding healthcare reform; Discussions regarding the Food and Drug Administration Reform Act (H.R. 5651); Discussions regarding Drug Safety and Accountability Act (S.1584)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
| ELIZABETH LEE WRIGHT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.